| Annual Report 2014 | 1 |
| CONTENTS | 8 |
| Corporate Profile | 10 |
| Corporate Information | 10 |
| Worldwide Operation | 11 |
| Financial Highlights | 12 |
| Chairman and Group CEO’s Joint Statement | 13 |
| Board of Directors | 16 |
| Profile of the Board of Directors | 17 |
| Health, Safety and Environment | 20 |
| Corporate Calendar | 22 |
| CR Calendar | 24 |
| Audit Committee | 26 |
| Remuneration Committee | 30 |
| Nomination Committee | 33 |
| Statement on Corporate Governance | 36 |
| Additional Compliance Information | 48 |
| Statement on Risk Management and Internal Control | 50 |
| Statement of Directors’ Responsibility | 52 |
| CONTENTS (Financial Statements) | 53 |
| Directors’ Report | 54 |
| Statement by Directors | 59 |
| Statutory Declaration | 59 |
| Independent Auditors’ Report | 60 |
| Statements of Financial Position | 62 |
| Statements of Profit or Loss | 64 |
| Statements of Other Comprehensive Income | 65 |
| Consolidated Statement of Changes in Equity | 66 |
| Company Statement of Changes in Equity | 68 |
| Statements of Cash Flows | 69 |
| Notes to the Financial Statements | 73 |
| 1. GENERAL INFORMATION | 73 |
| 2. SIGNIFICANT ACCOUNTING POLICIES | 73 |
| 3. CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS | 94 |
| 4. PROPERTY, PLANT AND EQUIPMENT | 95 |
| 5. PREPAID LEASE PAYMENTS | 100 |
| 6. BIOLOGICAL ASSETS | 101 |
| 7. INVESTMENT PROPERTIES | 102 |
| 8. INVESTMENT IN SUBSIDIARIES | 103 |
| 9. INVESTMENT IN ASSOCIATES | 113 |
| 10. INVESTMENT IN JOINT VENTURES | 117 |
| 11. AVAILABLE-FOR-SALE FINANCIAL ASSETS | 122 |
| 12. DERIVATIVE FINANCIAL ASSETS/(LIABILITIES) | 123 |
| 13. GOODWILL | 125 |
| 14. OTHER INTANGIBLE ASSETS | 127 |
| 15. DEFERRED TAX ASSETS/(LIABILITIES) | 128 |
| 16. LONG TERM DEPOSIT | 130 |
| 17. INVENTORIES | 130 |
| 18. AMOUNTS DUE FROM/(TO) CUSTOMERS ON CONTRACTS | 131 |
| 19. TRADE AND OTHER RECEIVABLES | 131 |
| 20. AMOUNTS OWING BY/(TO) SUBSIDIARIES | 135 |
| 21. AMOUNTS OWING BY/(TO) ASSOCIATES | 136 |
| 22. AMOUNTS OWING BY/(TO) JOINT VENTURES | 137 |
| 23. TIME DEPOSITS | 139 |
| 24. CASH AND BANK BALANCES | 140 |
| 25. ASSETS CLASSIFIED AS HELD FOR SALE | 141 |
| 26. SHARE CAPITAL | 142 |
| 27. SHARE PREMIUM | 142 |
| 28. TREASURY SHARES | 143 |
| 29. OTHER RESERVES | 144 |
| 30. WARRANTS RESERVE | 144 |
| 31. RETAINED PROFITS | 145 |
| 32. LOANS AND BORROWINGS | 145 |
| 33. TRADE AND OTHER PAYABLES | 149 |
| 34. PROVISION FOR WARRANTIES | 150 |
| 35. GROSS REVENUE | 151 |
| 36. COST OF SALES | 151 |
| 37. OTHER LOSSES - NET | 151 |
| 38. PROFIT FROM OPERATIONS | 152 |
| 39. FINANCE COSTS | 153 |
| 40. TAX EXPENSE | 154 |
| 41. EARNINGS PER SHARE ATTRIBUTABLE TO OWNERS OF THE COMPANY | 155 |
| 42. DIVIDENDS | 156 |
| 43. SIGNIFICANT ACQUISITIONS | 156 |
| 44. DISPOSAL OF SUBSIDIARIES | 158 |
| 45. SIGNIFICANT RELATED PARTY DISCLOSURES | 159 |
| 46. STAFF COSTS | 162 |
| 47. COMMITMENTS | 162 |
| 48. CONTINGENT LIABILITIES | 163 |
| 49. SEGMENTAL ANALYSIS | 164 |
| 50. FINANCIAL INSTRUMENTS BY CATEGORY | 172 |
| 51. FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES | 173 |
| 52. FAIR VALUES OF FINANCIAL INSTRUMENTS | 177 |
| 53. CAPITAL MANAGEMENT | 178 |
| Supplementary Information Disclosed | 179 |
| Summary of Significant Recurrent Related Party Transactions | 180 |
| Top 10 List of Properties | 182 |
| Analysis of Shareholdings | 183 |
| Notice of Fifteenth Annual General Meeting | 186 |
| Statement Accompanying Notice of Fifteenth Annual General Meeting | 191 |
| Proxy Form | 193 |